Skip to main content

Can metformin modulate the retinal degenerative changes in a rat model of retinitis pigmentosa?

Research Authors
Sohair A Eltony, Heba S Mohaseb, Amel A Ahmed, Manal M Sayed
Research Date
Research Department
Research Journal
Tissue and Cell
Research Publisher
Churchill Livingstone
Research Rank
International
Research Vol
76
Research Year
2022
Research_Pages
101786
Research Abstract

Retinitis pigmentosa (RP) affects over a million people worldwide, characterized by photoreceptor cell death, progressive retinal degeneration, and visual loss. Metformin is demonstrated as a potential therapeutic approach for preventing light-induced retinal degeneration by decreasing apoptosis and oxidative stress. This work aimed to investigate the effect of metformin on the retina of the N-Ethyl-N-nitrosourea (ENU) induced rat model of RP. Eighteen adult male Wistar rats were divided into two groups. Group I: normal vehicle control (N = 6). Group II: ENU-induced photoreceptor degeneration (N = 12) received a single intraperitoneal injection of ENU at a 600 mg/kg dose. Rats in group II were equally divided into two subgroups: IIa: photoreceptor degeneration-induced group and IIb: metformin-treated group (200 mg/kg) for seven days. Specimens from the retina were processed for light and electron microscopy …